The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
Clinical trial NCT02835534 · COMPLETED
Trial details
- NCT number
- NCT02835534
- Sponsor
- CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2019-10-01
- Enrollment
- 818
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.